Infectious Diseases – Products

At ESCMID Global, Bruker announced an expanded PCR assay menu for its BeGenius sample-to-answer system, new IR Tracker software for faster microbial strain typing, and automated sample preparation improvements for the MALDI Biotyper platform.

Oxford Nanopore and Cepheid to co-develop a rapid sequencing workflow for in-house infectious disease diagnostics.

Amsbio provides Heparan Sulfate monoclonal antibodies, crucial tools for glycobiology research, driving advances in cancer, immunology and viral infections.

FDA approves leading solution for latent tuberculosis diagnostics, advancing global effort to fight infectious diseases.

Bio-Rad Laboratories has launched the XP-Design Assay Salmonella Serotyping Solution to enhance food safety testing. Using real-time PCR technology, the assay enables fast and accurate detection of Salmonella serotypes.

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

Thermo Fisher Scientific introduces the Thermo Scientific™ TSX™ Core Series ULT freezers, designed to provide reliable performance and robust durability in a user-friendly solution.

On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

Revvity, Inc. (NYSE: RVTY), announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus.

This application note explores an innovative spectral flow cytometry method optimized for NK cell characterization.